![A method to determine pharmacokinetic parameters based on andante constant-rate intravenous infusion | Scientific Reports A method to determine pharmacokinetic parameters based on andante constant-rate intravenous infusion | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-017-13437-6/MediaObjects/41598_2017_13437_Fig1_HTML.jpg)
A method to determine pharmacokinetic parameters based on andante constant-rate intravenous infusion | Scientific Reports
![Frontiers | Factors Influencing the Steady-State Plasma Concentration of Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors and Chronic Myeloid Leukemia Frontiers | Factors Influencing the Steady-State Plasma Concentration of Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors and Chronic Myeloid Leukemia](https://www.frontiersin.org/files/Articles/569843/fphar-11-569843-HTML-r1/image_m/fphar-11-569843-g001.jpg)
Frontiers | Factors Influencing the Steady-State Plasma Concentration of Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors and Chronic Myeloid Leukemia
![Pharmacokinetics: The Dynamics of Drug Absorption, Distribution, Metabolism, and Elimination - Goodman and Gilman Manual of Pharmacology and Therapeutics Pharmacokinetics: The Dynamics of Drug Absorption, Distribution, Metabolism, and Elimination - Goodman and Gilman Manual of Pharmacology and Therapeutics](https://doctorlib.info/pharmacology/manual/manual.files/image020.jpg)
Pharmacokinetics: The Dynamics of Drug Absorption, Distribution, Metabolism, and Elimination - Goodman and Gilman Manual of Pharmacology and Therapeutics
![Chapter 15. Determination of Rate Constants | Handbook of Basic Pharmacokinetics… Including Clinical Applications, 7th Edition | PharmacyLibrary Chapter 15. Determination of Rate Constants | Handbook of Basic Pharmacokinetics… Including Clinical Applications, 7th Edition | PharmacyLibrary](https://pharmacylibrary.com/cms/10.21019/9781582121260.ch15/asset/images/medium/rits7_c015f002.gif)